Mhatre Radhika, Poyuran Rajalakshmi, Arimappamagan Arivazhagan, Sinha Sanjib, Kulanthaivelu Karthik, Kenchaiah Raghavendra, Ajay Asranna, Chowdary Ravindranadh M, Saini Jitender, Bharath Rose Dawn, Zanzmera Paresh, Seetharam Raghavendra, Sadashiva Nishanth, Jamuna Rajan, Satishchandra Parthasarathy, Malla Bhaskara Rao, Sk Shankar, Anita Mahadevan
Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Epilepsy Res. 2020 Dec;168:106472. doi: 10.1016/j.eplepsyres.2020.106472. Epub 2020 Sep 22.
Neurocysticercosis (NCC) as cause of drug resistant epilepsy (DRE) is commonly reported from India. We reviewed the neuropathological findings in patients undergoing resective surgery for DRE due to NCC, to determine the pathomechanism of epileptogenesis.
Clinical, demographic and neuropathological findings of histologically confirmed cases of NCC causing DRE between 2005-2019 were reviewed. NeuN, GFAP, phosphorylated neurofilament, vimentin, CD34 for glial/ neuronal alterations, and Masson trichrome, Luxol Fast blue for evidence of fibrosis/ demyelination was used to determine cause of epileptogenesis.
There were 12 cases of NCC associated with dual/ double pathology, which constituted 3.02 % (12/398) of all the operated DRE. [Age range: 17-37y, Male:Female = 1.4:1]. Seizure duration ranged from 3-32y, with seizure onset between 4-27y. On MRI, lesions were of variable signal intensity on T1 and isointense on T2 with blooming on GRE/ SWI, and CT revealed calcification. Majority (11/12) had associated hippocampal sclerosis (HS) type 1 (dual pathology), localised to the same side as cysticercal cyst, suggesting it may be involved in the pathogenesis of HS. Ten had single cysticercal lesion involving ipsilateral hippocampus in 6, parahippocampal gyrus in 2, amygdala and temporal lobe in 1 case each. One had multiple NCC located in bilateral frontal, parietal and ipsilateral hippocampus. Adjacent cortex around the NCC evaluated in 6 cases, revealed inflammation, gliosis, axonal disruption/ beading, and variable synaptic/ neuronal dystrophic changes. There was a single case of NCC with Focal cortical dysplasia (FCD) type IIb (double pathology). In 11/12 cases Engel's post-surgery outcome was available with all having class I outcome.
HS was most common pathology associated with cysticercosis (Dual pathology), localised ipsilateral to the cysticercal cyst, suggesting that HS is a secondary/ epiphenomenon. Perilesional changes such as inflammation, gliosis, dystrophic synaptic and axonal pathology play a role in inducing or perpetuating the epileptiform activity. The association of FCD IIb with NCC in one case is likely to be a chance occurrence.
在印度,神经囊尾蚴病(NCC)作为耐药性癫痫(DRE)的病因屡有报道。我们回顾了因NCC导致DRE而接受切除手术患者的神经病理学发现,以确定癫痫发生的病理机制。
回顾了2005年至2019年间经组织学确诊的由NCC导致DRE病例的临床、人口统计学和神经病理学发现。使用神经元核抗原(NeuN)、胶质纤维酸性蛋白(GFAP)、磷酸化神经丝、波形蛋白、CD34来检测神经胶质/神经元改变,并用马松三色染色法、卢氏固蓝染色法检测纤维化/脱髓鞘证据,以确定癫痫发生的原因。
有12例NCC伴有双重病理改变,占所有接受手术的DRE病例的3.02%(12/398)。[年龄范围:17 - 37岁,男∶女 = 1.4∶1]。癫痫发作持续时间为3 - 32年,发作起始于4 - 27岁。在磁共振成像(MRI)上,病变在T1加权像上信号强度各异,在T2加权像上呈等信号,在梯度回波/磁敏感加权成像(GRE/SWI)上有磁敏感伪影,计算机断层扫描(CT)显示有钙化。大多数(11/12)伴有1型海马硬化(HS)(双重病理改变),定位于与囊尾蚴囊肿同侧,提示其可能参与HS的发病机制。10例有单个囊尾蚴病变,其中6例累及同侧海马,2例累及海马旁回,1例分别累及杏仁核和颞叶。1例有多个NCC,位于双侧额叶、顶叶和同侧海马。对6例NCC周围的邻近皮质进行评估,发现有炎症、胶质增生、轴突中断/串珠样改变以及不同程度的突触/神经元营养不良性改变。有1例NCC合并IIb型局灶性皮质发育不良(FCD)(双重病理改变)。11/12例有恩格尔术后结果,均为I级结果。
HS是与囊尾蚴病相关的最常见病理改变(双重病理改变),定位于囊尾蚴囊肿同侧,提示HS是一种继发性/附带现象。病灶周围改变,如炎症、胶质增生、营养不良性突触和轴突病理改变,在诱发或维持癫痫样活动中起作用。1例中FCD IIb与NCC的关联可能是偶然发生。